Mass spectrometry

In a peptide COA, mass spectrometry peptide testing is an identity check: the instrument ionizes a peptide, reads its mass-to-charge signals, and compares the calculated molecular mass with the value expected for the named molecule. HPLC answers the separate purity question, so a clean sample of the wrong peptide can still look 99% pure.

What is mass spectrometry?

Mass spectrometry measures charged molecules by their mass-to-charge ratio, written m/z. Software accounts for the charge state and works back to the peptide’s molecular mass. If that observed mass matches the value predicted from the intended amino-acid sequence, the result supports the answer, “this is the expected molecule.”

The instrument does not literally put one molecule on a tiny bathroom scale. It turns molecules into ions, separates those ions according to m/z, and records a spectrum of signals. The expected value comes from the peptide’s formula and molecular weight.

What does a peptide identity test prove?

A peptide identity test based on intact mass provides strong evidence that the sample has the expected molecular mass, but mass alone does not always settle the complete structure. Different sequences or isobaric amino acids can share the same mass. Tandem mass spectrometry, written MS/MS, breaks selected peptide ions into fragments and compares that pattern with the expected sequence.

That distinction keeps the evidence tier honest. The NIH-hosted peptide characterization recommendations call for mass-spectrometry data, preferably MS/MS, alongside an HPLC-UV chromatogram. A USP-led study likewise describes multiple complementary identity methods when closely related structures must be distinguished. A mass match is useful evidence, not a magic stamp.

Mass spec vs HPLC: why does a COA need both?

Mass spec vs HPLC is identity versus purity. HPLC separates the sample and estimates how much of the detected material belongs to its main peak; mass spectrometry asks whether that material has the expected mass. Neither answer substitutes for the other, which is why a useful MS test on a peptide COA sits beside the chromatogram.

Take BPC-157, a 15-amino-acid peptide in the wider peptide reference. A vial containing one very pure wrong compound could produce a tidy HPLC trace. Mass spectrometry peptide testing checks whether the main material weighs what BPC-157 should; MS/MS can add sequence-level evidence. The full peptide COA workflow belongs on its own page. The clean split here is enough: HPLC asks, “is it pure?” Mass spectrometry asks, “is it the right molecule?”